• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Valeant completes sale of Dendreon to Sanpower for $819.9m pharmaceutical-technology
    July 04, 2017
    Canadian company Valeant Pharmaceuticals International has completed the sale of all outstanding equity interests in its subsidiary Dendreon Pharmaceuticals to the Sanpower Group for $819.9m. 
  • Sanpower Group to Acquire Dendreon from Valeant for $819.9M americanpharmaceuticalreview
    January 11, 2017
    Sanpower Group, one of the largest privately owned conglomerates in China, reached an agreement with Valeant, a world's leading pharmaceutical company, to acquire a 100% stake in its US biopharmaceutical company Dendreon for $819.9 million.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service